Pediatrics Doctors in Concord, MA Accepting Medicare

24 Pediatrics doctors found. Showing 21 - 24

Dr. Nana Girgis Mcmahon, Pediatrics - Neonatal-Perinatal Medicine Medicare: Medicare Enrolled Practice Location: 131 Ornac, Suite 470, Concord, MA 01742 Phone: 978-369-5050    Fax: 978-371-7292

Dr. Eshita Minesh Bakshi, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 101 Thoreau St, Concord, MA 01742 Phone: 978-369-9401

Dr. Eileen Murray, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 330 Baker Ave, Concord, MA 01742 Phone: 978-287-9400    Fax: 978-287-9408

Charlotte C Cowan, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 281 A Fairhaven Hill, Concord, MA 01742 Phone: 978-369-0739

News Archive

SunLink second quarter consolidated net revenues decrease 4.0% to $27,850,000

SunLink Health Systems, Inc. today announced net earnings for its second fiscal quarter ended December 31, 2012 of $3,935,000, or $0.42 per fully diluted share, compared to a net loss of $935,000, or a loss of $0.10 per fully diluted share, for the quarter ended December 31, 2011.

Data can help scientists, physicians match precision drugs to cancer's genetic traits

More than 5,000 genetic profiles of tumor DNA have been completed in a large research study by scientists at Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Boston Children's Hospital designed to speed the development of personalized cancer care with precision treatments.

Cosmetic surgery appeals to men, women with appearance-based rejection sensitivity

Researchers have found that men and women who feel sensitive to rejection based on their physical appearance are more likely to express interest in having cosmetic surgery than those who are less sensitive to appearance-based rejection. This effect is particularly true when people recall negative comments about their physical appearance.

BDSI Sciences to purchase $10M of securities in registered direct offering

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, announced that it has entered into a definitive securities purchase agreement with a group of select institutional investors to purchase US$10 million of its securities in a registered direct offering. No placement agent was utilized in connection with the offering.

VIROPRO provides updates on business

VIROPRO today provided updates on its business. Stockholders meeting was postponed because items to be voted upon by stockholders required production of the audited financial statements and these are not yet available.

Read more Medical News

› Verified 2 days ago

• 1
• 2(current)